Company intelligence / Profile preview

Beijing Kexing Zhongwei Biotechnology Co., Ltd.

Beijing, Beijing, Chinasinovac.com ↗
Ownership
Private
Employees
~1000
Development stage
Commercial
01

Overview

The company has developed multiple WHO-prequalified vaccines including inactivated hepatitis A vaccine and polio vaccine. Its COVID‑19 vaccine CoronaVac was among the first globally approved for emergency use and has been widely distributed internationally. Clinical trials have demonstrated strong immunogenicity with favorable safety profiles across age groups. The pipeline also includes new pneumococcal conjugate vaccines currently in early clinical stages.

Therapeutic areas
PulmonologyNeurologyInfectious Diseases
Modalities
Prophylactic vaccinesInactivated vaccinesConjugated vaccinesLive attenuated vaccineImmunostimulant
Industry
Biotech
02

Drug pipeline

2 assets

SNA02-48

3

1 more asset in the full pipeline.

Request access →
03

Partnerships

PT Bio Farma Indonesia—technology transfer/licensing/manufacturing partnership for CoronaVac supply to IndonesiaMultiple international collaborations for global distribution of COVID–19 and other vaccines.

Beyond the preview

Go deeper on Beijing Kexing Zhongwei Biotechnology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Kexing Zhongwei Biotechnology Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call